Levine James E. 4
4 · Cardiff Oncology, Inc. · Filed Jul 12, 2021
Insider Transaction Report
Form 4
Levine James E.
Chief Financial Officer
Transactions
- Award
Common Stock
2021-07-12+390,000→ 390,000 totalExercise: $6.55Exp: 2031-07-12→ Stock Options (390,000 underlying)
Footnotes (1)
- [F1]97,500 vest on 7/12/2022. 8,125 vest monthly for 36 months beginning on 8/12/2022 through 7/12/2025.